# CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT

- Link: https://www.thailand-business-news.com/pr-news/cheplapharm-to-accelerate-global-supply-chain-digitalization-with-tracelink-mint
- Published: 2026-05-14T21:00:00+07:00
- Author: PR Newswire

|   |

_The German pharmaceutical company unifies its digital partner network, laying the
foundation for AI-driven supply chain orchestration_

BOSTON, May 14, 2026 /PRNewswire/ — TraceLink, the world’s largest Agentic Business
Network, today announced that the German-based but globally active CHEPLAPHARM Group,
a world leader in the acquisition of original preparations from the research-based
pharmaceutical industry, is going live on the TraceLink network with [Multienterprise Information Network Tower](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4688273-1&h=641516850&u=https%3A%2F%2Fwww.tracelink.com%2Fproducts%2Fpartner-orchestration%2Fmint&a=Multienterprise+Information+Network+Tower)(
MINT), powered by [Orchestration Platform for Universal Solutions](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4688273-1&h=1263704991&u=https%3A%2F%2Fwww.tracelink.com%2Fnetwork%2Fopus-platform&a=Orchestration+Platform+for+Universal+Solutions)(
OPUS).

**Unified Digital ****Operations ****Through MINT As CHEPLAPHARM expanded its portfolio
and global trading partner network through ongoing acquisitions, the company recognized
the need to standardize and automate supply chain operations. Core processes—such
as purchase order confirmations, delivery date updates, and shipment notifications—
were handled manually through emails and non-standardized documents like PDFs and
Excel sheets, creating additional administrative workload.

By implementing MINT, CHEPLAPHARM will be able to exchange mission-critical data
digitally and in real time between ERP systems, reducing manual effort, improving
transparency, and enabling more efficient, scalable operations with its partners.
This will mark a major step toward seamless, data-driven orchestration across CHEPLAPHARM’s
growing trading partner ecosystem.

"We reached a point in our growth where manual workflows were creating unnecessary
delays and repeated work across both our organization and our partners’ operations,"
said Luise Daberkow, Senior Business Process Manager at CHEPLAPHARM. "By moving 
to TraceLink, we will eliminate time-consuming email chains and manual data entry,
allowing our teams to focus on more strategic initiatives. We will have real-time
operational visibility and agility to scale our business and partnerships in tandem."

**Accelerating Partner Onboarding Through a Single LinkA key factor in CHEPLAPHARM’s
decision to implement TraceLink was the ability to onboard partners rapidly and 
at no cost to them. Unlike traditional point-to-point integration models that require
building and maintaining separate connections for every trading partner, TraceLink’s
B2N Integrate-Once™ model allows CHEPLAPHARM and its trading partners to link a 
single time to the network, with no subscription or setup fees for CHEPLAPHARM’s
partners. This model will eliminate the need to rebuild interfaces each time a new
partner joins, helping reduce the cost, effort, and friction of digitalizing transactions
and processes across trading partners, while reducing IT workload and integration
complexity.

**IT Team-Backed Digitalization Reduces Complexity and Boosts Operational Resilience**

Acting as a flexible orchestration layer between CHEPLAPHARM’s SAP environment and
the diverse ERP systems used by its global CMOs and suppliers, MINT allows seamless,
standardized data exchange without requiring heavy customization or system changes.

This standardized approach will not only ensure data integrity and GxP‑compliant
communication but also eliminate repeated validation cycles and regression testing
typically required for point-to-point EDI connections. By reusing validated interfaces
and minimizing the need for tailor‑made integrations, the IT team will gain significant
time savings, reduce reliance on external consultants, and improve long‑term system
scalability.

**The Foundation for Agentic OrchestrationWith a strong foundation in automation
and partner integration, CHEPLAPHARM is advancing its digitalization strategy to
strengthen supply chain resilience and agility. This approach will not only enhance
current operations but will also future-proof the company’s MINT investment—creating
the conditions to leverage emerging agent-based intelligence capabilities as they
mature.

"CHEPLAPHARM is taking a forward-looking approach that not only improves operational
efficiency but prepares for the next era of supply chain intelligence," said Shabbir
Dahod, President and CEO of TraceLink. "Network-based digitalization is the infrastructure
on which agentic AI can deliver real, trusted, and responsible value across the 
life sciences supply chain."

To learn how companies are building the digital foundation for agentic supply chain
execution with TraceLink, visit [tracelink.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4688273-1&h=1261991504&u=https%3A%2F%2Fwww.tracelink.com%2Fai-mode%3Fquery%3DWhy%2Bare%2BOPUS%2BAgents%2Bdifferent%2Bfrom%2Bother%2Bagentic%2Bcapabilities&a=tracelink.com).

**About TraceLinkTraceLink is the world’s largest Agentic Business Network, enabling
life sciences and healthcare companies to build and manage a scalable digital workforce
of governed, no-code AI agents that execute and coordinate mission-critical supply
chain operations alongside human teams.

Powered by the Integrate-Once™ OPUS platform, which links 315,000+ authenticated
network entities that exchange hundreds of billions of product transactions annually,
only TraceLink delivers the industrial foundation required to develop, train, and
continuously optimize agentic supply chain talent—governed AI agents—operating across
multienterprise processes.

This agentic workforce model redefines how work gets done—expanding capacity, accelerating
execution, and enabling safe, secure supply chain ecosystems that serve the greater
good and operate with unprecedented agility, intelligence, and productivity beyond
the limits of human-only operations, ensuring patients receive safe, high-quality
therapies and products when and where they are needed.

Learn more at [www.tracelink.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4688273-1&h=1768895475&u=http%3A%2F%2Fwww.tracelink.com%2F&a=www.tracelink.com).

**About CHEPLAPHARMCHEPLAPHARM is a family-owned company with headquarters in Greifswald.
For over 20 years, the company has been very successful in taking over well-known
and well-established medicines from the research-based pharmaceutical industry and
transferring them to an existing global network of partners for production and distribution.
In this way, CHEPLAPHARM ensures the continuous supply of these medicines to patients
worldwide. In addition to its headquarters in Greifswald, CHEPLAPHARM operates further
sites in France, Japan, Russia and Switzerland. The company employs about 800 people
worldwide.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT ](http://www.prnasia.com/story/archive/4959144_AE59144_0?rand=184833)
